Related Experiment Video

Updated: Aug 23, 2025

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Corrigendum to: Molecular alterations associated with improved outcome in patients with glioblastoma treated with

Neuro-Oncology Advances

|November 3, 2022

Abstract:

[This corrects the article DOI: 10.1093/noajnl/vdac096.].

More Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields TTFields

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields TTFields

Published on: May 4, 2017

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Poor brain reserve increases mortality risk in glioblastoma.

Neuro-oncology advances·2026

Combination treatment with RAF/MEK inhibitor avutometinib and FAK inhibitor defactinib in preclinical models of meningioma.

Neuro-oncology advances·2026

TP53 mutation is associated with selective upregulation of LAG3 independent of immune infiltration and antigen-presentation signatures in WHO grade 4 glioma.

Neuro-oncology advances·2026

Targeting the Siglec/sialic-acid axis in glioblastoma: Glycome-mediated immune evasion and emerging therapeutic platforms.

Neuro-oncology advances·2026

Nationally recruited telehealth group-based Cognitive Behavioral Therapy for Insomnia in patients with primary brain tumors: A randomized NIH ORBIT Phase IIc study.

Neuro-oncology advances·2026

Permeabilization of tumor margins in brain macrometastases using a type-1 receptor selective tumor necrosis factor mutein.

Neuro-oncology advances·2026

See all related articles